HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


WLP: Wellpoint Inc - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
WELLPOINT INC (NYSE)
WLP 52.14 N/A (N/A%) Vol.  3,459,444 16:00 ET
WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through HealthLink and UniCare.

 General Information
WELLPOINT INC
120 Monument Circle
Indianapolis, IN 46204
Phone: 317 488-6000
Fax: 317 488-6703
Web: www.wellpoint.com
Email: michael.kleinman@wellpoint.com
 
Industry MED-HMO
Sector: Medical
 
Fiscal Year End December
Last Reported Quarter 09/30/09
Next EPS Date 01/27/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 52.14
52 Week High 55.73
52 Week Low 29.32
Beta 1.10
20 Day Moving Average 4,249,425.00
Target Price Consensus 58.82
 
 % Price Change
4 Week 13.27
12 Week -2.94
YTD 23.76
 % Price Change Relative to S&P 500
4 Week 12.05
12 Week -8.49
YTD 2.43
 Share Information
Shares Outstanding (millions) 475.06
Market Capitalization (millions) 24,769.47
Short Ratio 0.73
Last Split Date 06/01/2005
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 1.06
Current Year EPS Consensus Estimate 5.92
Estimated Long-Term EPS Growth Rate 11.30
Next EPS Report Date 01/27/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.14
30 Days Ago 2.08
60 Days Ago 2.03
90 Days Ago 2.03

 Fundamental Ratios
 P/E
Current FY Estimate: 8.81
Trailing 12 Months: 8.45
PEG Ratio 0.78
 EPS Growth
vs. Previous Year 12.66%
vs. Previous Quarter 24.48%
 Sales Growth
vs. Previous Year 3.10%
vs. Previous Quarter: 1.04%
 Price Ratios
Price/Book 1.08
Price/Cash Flow 7.72
Price / Sales 0.41
 ROE
09/30/09 13.78
06/30/09 13.79
03/31/09 14.22
 ROA
09/30/09 6.17
06/30/09 6.08
03/31/09 6.15
 Current Ratio
09/30/09 1.80
06/30/09 1.74
03/31/09 0.81
 Quick Ratio
09/30/09 1.80
06/30/09 1.74
03/31/09 0.81
 Operating Margin
09/30/09 4.98
06/30/09 4.95
03/31/09 5.01
 Net Margin
09/30/09 5.86
06/30/09 4.97
03/31/09 5.15
 Pre-Tax Margin
09/30/09 5.86
06/30/09 4.97
03/31/09 5.15
 Book Value
09/30/09 48.14
06/30/09 45.92
03/31/09 43.15
 Inventory Turnover
09/30/09 -
06/30/09 -
03/31/09 -
 Debt-to-Equity
09/30/09 0.37
06/30/09 0.38
03/31/09 0.40
 Debt to Capital
09/30/09 26.83
06/30/09 27.67
03/31/09 28.39

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research